company background image
6MK logo

Merck DB:6MK Stock Report

Last Price

€115.60

Market Cap

€293.0b

7D

3.0%

1Y

17.4%

Updated

26 Mar, 2024

Data

Company Financials +

Merck & Co., Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Merck
Historical stock prices
Current Share PriceUS$115.60
52 Week HighUS$120.00
52 Week LowUS$90.70
Beta0.38
1 Month Change-3.67%
3 Month Change18.81%
1 Year Change17.36%
3 Year Change73.57%
5 Year Change55.56%
Change since IPO283.55%

Recent News & Updates

Recent updates

Shareholder Returns

6MKDE PharmaceuticalsDE Market
7D3.0%2.3%1.9%
1Y17.4%-25.9%7.3%

Return vs Industry: 6MK exceeded the German Pharmaceuticals industry which returned -26.3% over the past year.

Return vs Market: 6MK exceeded the German Market which returned 6.4% over the past year.

Price Volatility

Is 6MK's price volatile compared to industry and market?
6MK volatility
6MK Average Weekly Movement2.6%
Pharmaceuticals Industry Average Movement6.3%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.1%
10% least volatile stocks in DE Market2.4%

Stable Share Price: 6MK has not had significant price volatility in the past 3 months.

Volatility Over Time: 6MK's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
189171,000Rob Davishttps://www.merck.com

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes under the Keytruda, Bridion, Adempas, Lagevrio, Belsomra, Simponi, and Januvia brands, as well as vaccine products consisting of preventive pediatric, adolescent, and adult vaccines under the Gardasil/Gardasil 9, ProQuad, M-M-R II, Varivax, RotaTeq, Live Oral, Vaxneuvance, Pneumovax 23, and Vaqta names.

Merck & Co., Inc. Fundamentals Summary

How do Merck's earnings and revenue compare to its market cap?
6MK fundamental statistics
Market cap€293.02b
Earnings (TTM)€337.00m
Revenue (TTM)€55.50b

871.0x

P/E Ratio

5.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
6MK income statement (TTM)
RevenueUS$60.12b
Cost of RevenueUS$15.92b
Gross ProfitUS$44.20b
Other ExpensesUS$43.84b
EarningsUS$365.00m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Apr 25, 2024

Earnings per share (EPS)0.14
Gross Margin73.53%
Net Profit Margin0.61%
Debt/Equity Ratio93.1%

How did 6MK perform over the long term?

See historical performance and comparison

Dividends

2.5%

Current Dividend Yield

2,030%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.